The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled …
HM Cheng, LC Chiang, YM Jan, GW Chen… - International Archives of …, 2011 - karger.com
… of Chinese herbal medicine for atopic dermatitis [5] … atopic dermatitis in Asian clinical practice.
The purpose of this study was to evaluate the efficacy and safety of XFS in atopic dermatitis…
The purpose of this study was to evaluate the efficacy and safety of XFS in atopic dermatitis…
… , double‐blind, placebo‐controlled trial to investigate the efficacy and safety of a Chinese herbal product (P07P) for the treatment of canine atopic dermatitis
TM Nagle, SM Torres, KL Horne, R Grover… - Veterinary …, 2001 - Wiley Online Library
… remedy, was undertaken in 50 dogs with atopic dermatitis. Owners recorded a daily itch score
for 4–… as a novel nonsteroidal therapy for the management of dogs with atopic dermatitis. …
for 4–… as a novel nonsteroidal therapy for the management of dogs with atopic dermatitis. …
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis
S Reitamo, M Rustin, T Ruzicka, F Cambazard… - Journal of allergy and …, 2002 - Elsevier
… the efficacy and safety of tacrolimus ointment for patients with atopic dermatitis. Objective: …
patients with moderate-to-severe atopic dermatitis. Methods: Patients applied ointment twice …
patients with moderate-to-severe atopic dermatitis. Methods: Patients applied ointment twice …
Efficacy and safety of oral Janus kinase 1 inhibitor abrocitinib for patients with atopic dermatitis: a phase 2 randomized clinical trial
MJ Gooderham, SB Forman, R Bissonnette… - JAMA …, 2019 - jamanetwork.com
… abrocitinib was effective and well tolerated for short-term use in adults with moderate to
severe atopic dermatitis. Additional trials are necessary to evaluate long-term efficacy and safety. …
severe atopic dermatitis. Additional trials are necessary to evaluate long-term efficacy and safety. …
Efficacy and safety of mepolizumab administered subcutaneously for moderate to severe atopic dermatitis.
EG Kang, PK Narayana, IJ Pouliquen, MC Lopez… - Allergy, 2020 - search.ebscohost.com
… and survival of eosinophils which may be therapeutic in subjects with atopic dermatitis (AD).…
management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. …
management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. …
Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis
T Werfel, G Layton, M Yeadon, L Whitlock… - Journal of Allergy and …, 2019 - Elsevier
… We sought to study the efficacy and safety of ZPL-3893787 (a selective H 4 receptor antagonist)
… The aim of this study was to investigate the efficacy and safety of ZPL-3893787 in adults …
… The aim of this study was to investigate the efficacy and safety of ZPL-3893787 in adults …
[HTML][HTML] Long-term efficacy and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis: results through week 52 from a phase III open-label …
A Blauvelt, E Guttman-Yassky, AS Paller… - American journal of …, 2022 - Springer
… Dupilumab is a newer treatment for atopic dermatitis. In short-term clinical studies, … with
acceptable safety. In this study, adolescents with moderate-to-severe atopic dermatitis who had …
acceptable safety. In this study, adolescents with moderate-to-severe atopic dermatitis who had …
Efficacy and safety of lebrikizumab, a high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: a phase 2b randomized clinical trial
… and safety of dupilumab for the treatment of atopic dermatitis … , was generally well tolerated,
and had a favorable safety … of interleukin 13 in the pathophysiology of atopic dermatitis. …
and had a favorable safety … of interleukin 13 in the pathophysiology of atopic dermatitis. …
The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study
Y Zhao, L Wu, Q Lu, X Gao, X Zhu, X Yao… - British Journal of …, 2022 - academic.oup.com
… 8 and the efficacy and safety of dupilumab in the Chinese population remain unclear.
Therefore, this study was conducted to evaluate the efficacy and safety of dupilumab monotherapy …
Therefore, this study was conducted to evaluate the efficacy and safety of dupilumab monotherapy …
A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client‐owned dogs
PR Little, VL King, KR Davis, SB Cosgrove… - Veterinary …, 2015 - Wiley Online Library
… Ciclosporin is approved for the treatment of atopic dermatitis (AD) in dogs and has been
shown to be safe and effective. Placebo-controlled studies suggest that oclacitinib is a safe and …
shown to be safe and effective. Placebo-controlled studies suggest that oclacitinib is a safe and …